Stock Alert: Arcutis Biotherapeutics Falls 15%

Shares of Arcutis Biotherapeutics, Inc. (ARQT) slipped nearly 15% on Friday morning. The company announced it has made a secondary offering with 4 million shares of its stock.

ARQT is currently trading at $23.63, up $4.00 or 14.46%, on the Nasdaq.

Westlake Village, California-based Arcutis, which focuses on skin treatments, plans to offer 4 million shares at offering price of $25.00 per share to raise $100 million in proceeds. In conjunction with the offering, the company will sell $35 million in stock to OrbiMed Advisors, an affiliate of one of its directors, in a private placement.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Swiss luxury goods group Compagnie Financiere Richemont AG reported Friday significantly higher profit in fiscal 2022 with strong growth in demand. The company also lifted its dividend, and announced a special dividend. Meanwhile, the shares were losing around 12 percent in the morning trading in Switzerland. Coeurd-Alene, Idaho-based White Cane Smoked Salmon LLC is recalling Wild Alaskan Cooked and Smoked Salmon as it contains undeclared wheat and soy, known allergens, the U.S. Food and Drug Administration said. The affected Alaskan Cooked and Smoked Salmon is packaged in vacuum bag, sold frozen, and there is no lot code or best by date on a package. Auto giant Ford Motor Co. (F) has issued a recall of about 39,000 2021 Expedition and Lincoln Navigator vehicles due to fire risk. The company has asked the customers of the recalled 2021 Ford Expedition and Lincoln Navigator SUVs to park their vehicles outside and away from structures while it investigates...
Follow RTT